Centessa制药公司将在2025年11月的两次投资者会议上介绍临床和业务最新情况。 Centessa Pharmaceuticals to present clinical and business updates at two investor conferences in November 2025.

Centessa制药公司宣布,它将出席2025年11月即将举行的两次投资者会议,包括在纽约举行的2025年H.C.Wainwright全球投资会议和在波士顿举行的2025年SVB Leerink保健会议。 Centessa Pharmaceuticals plc announced it will attend two upcoming investor conferences in November 2025, including the 2025 H.C. Wainwright Global Investment Conference in New York and the 2025 SVB Leerink Healthcare Conference in Boston. 公司将在活动期间介绍其临床发展方案和业务战略的最新情况。 The company will present updates on its clinical development programs and business strategy during the events. 公告中未披露任何具体数据或财务结果。 No specific data or financial results were disclosed in the announcement.